CTOs on the Move

Corcept Therapeutics

www.corcept.com

 
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. The company is also developing Korlym’s active ingredient, which is in a Phase 1/2 ...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.corcept.com
  • 149 Commonwealth Dr
    Menlo Park, CA USA 94025
  • Phone: 650.327.3270

Executives

Name Title Contact Details

Similar Companies

AstraZeneca Pharmaceuticals LP

AstraZeneca Pharmaceuticals LP is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Horizon Pharma

At Horizon Therapeutics, we believe science and compassion must work together to transform lives. We are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. For us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.

ValueOptions

ValueOptions Inc., the nation's largest independent behavioral health care and wellness company, specializes in management for all behavioral health issues, and mental health and chemical dependency diagnoses.

Physician's Choice

Physician's Choice, Inc. is a Destin, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ProTom International

Protoms Radiance 330 Proton Therapy System is compact, customizable, and has the industrys fastest return on investment.